» Articles » PMID: 23738181

A Unique Cause of Intestinal and Splenic Infarction in a Sickle Cell Trait Patient

Overview
Journal Case Rep Surg
Publisher Wiley
Specialty General Surgery
Date 2013 Jun 6
PMID 23738181
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Sickle-cell trait is a common genetic abnormality in the African American population. A sickle-cell crisis in a patient with sickle-cell trait is uncommon at best. Abdominal painful crises are typical of patients with sickle cell anemia. The treatment for an abdominal painful crisis is usually medical and rarely surgical. We present the case of a cocaine-induced sickle-cell crisis in a sickle-cell trait patient that resulted in splenic, intestinal, and cerebral infarctions and multisystem organ failure necessitating a splenectomy, subtotal colectomy, and small bowel resection. This case highlights the diagnostic dilemma that abdominal pain can present in the sickle-cell population and illustrates the importance of recognizing the potential for traditionally medically managed illnesses to become surgical emergencies.

Citing Articles

Sickle Cell Trait, Clinical Manifestations and Outcomes: A Cross-Sectional Study in Colombia: Increasing Rate of Symptomatic Subjects Living in High Altitude.

Vargas-Hernandez D, Uscategui-Ruiz A, Prada-Rueda A, Romero-Sanchez C Mediterr J Hematol Infect Dis. 2023; 15(1):e2023015.

PMID: 36908870 PMC: 10000961. DOI: 10.4084/MJHID.2023.015.


Gastrointestinal vaso-occlusive crisis in sickle cell disease.

Gautam G, Harmon R, Foley R Proc (Bayl Univ Med Cent). 2022; 35(6):856-857.

PMID: 36304615 PMC: 9586610. DOI: 10.1080/08998280.2022.2108995.


A Unique Case of Nonhypoxic Splenic Infarction in a Patient With Sickle Cell Trait Due to Dehydration and Sepsis From a Dental Infection: A Case Report.

Chaughtai S, Akram W, Chaughtai K, Chaughtai Z, Asif A Cureus. 2022; 14(7):e26645.

PMID: 35949746 PMC: 9356767. DOI: 10.7759/cureus.26645.


Splenic infarction in sickle cell trait: A comprehensive systematic review of case studies.

Jefferson J, Sims W, Umeh N, Byeon Y, Abdallah K, Bonham V EJHaem. 2021; 2(3):585-600.

PMID: 34870278 PMC: 8635393. DOI: 10.1002/jha2.248.


Safety of pegfilgrastim (neulasta) in patients with sickle cell trait/anemia.

Kasi P, Patnaik M, Peethambaram P Case Rep Hematol. 2014; 2013:146938.

PMID: 24396616 PMC: 3874362. DOI: 10.1155/2013/146938.

References
1.
Ferguson Jr E . Abdominal manifestations of sickle cell anemia. Hosp Pract (Off Ed). 1985; 20(10A):83-9, 93-5, 98-103. View

2.
Green M, Noguchi C, Keidan A, Marwah S, Stuart J . Polymerization of sickle cell hemoglobin at arterial oxygen saturation impairs erythrocyte deformability. J Clin Invest. 1988; 81(6):1669-74. PMC: 442609. DOI: 10.1172/JCI113504. View

3.
Boulmay B, Lottenberg R . Cocaine abuse complicating acute painful episodes in sickle cell disease. South Med J. 2008; 102(1):87-8. DOI: 10.1097/SMJ.0b013e318188b2ab. View

4.
BUNN H . Pathogenesis and treatment of sickle cell disease. N Engl J Med. 1997; 337(11):762-9. DOI: 10.1056/NEJM199709113371107. View

5.
Sheikha A . Splenic syndrome in patients at high altitude with unrecognized sickle cell trait: splenectomy is often unnecessary. Can J Surg. 2005; 48(5):377-81. PMC: 3211898. View